Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rick Doblin

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Focus (American Psychiatric Publishing)|July 5, 2023
Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and SertralineAllison A Feduccia, Lisa Jerome, Berra Yazar-Klosinski, et al.
Frontiers in Pharmacology|June 7, 2021
Relational Processes in Ayahuasca Groups of Palestinians and IsraelisLeor Roseman, Yiftach Ron, Antwan Saca, et al.
Journal of Psychopharmacology (Oxford, England)|June 21, 2022
MDMA-assisted therapy for posttraumatic stress disorder: A pooled analysis of ethnoracial differences in efficacy and safety from two Phase 2 open-label lead-in trials and a Phase 3 randomized, blinded placebo-controlled trialTerence Hw Ching, Monnica T Williams, Julie B Wang, et al.
Journal of Psychiatric Research|March 10, 2022
MDMA-assisted therapy significantly reduces eating disorder symptoms in a randomized placebo-controlled trial of adults with severe PTSDTimothy D Brewerton, Julie B Wang, Adele Lafrance, et al.
Journal of Psychopharmacology (Oxford, England)|June 22, 2017
Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapyMark T Wagner, Michael C Mithoefer, Ann T Mithoefer, et al.
Psychopharmacology|June 6, 2020
Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trialsLisa Jerome, Allison A Feduccia, Julie B Wang, et al.
Psychopharmacology|May 9, 2019
MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trialsMichael C Mithoefer, Allison A Feduccia, Lisa Jerome, et al.
Drug and Alcohol Dependence|March 14, 2022
The effects of MDMA-assisted therapy on alcohol and substance use in a phase 3 trial for treatment of severe PTSDChristopher R Nicholas, Julie B Wang, Allison Coker, et al.
Journal of Psychopharmacology (Oxford, England)|November 23, 2012
Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up studyMichael C Mithoefer, Mark T Wagner, Ann T Mithoefer, et al.
Plos One|January 10, 2024
Effects of MDMA-assisted therapy for PTSD on self-experienceBessel A van der Kolk, Julie B Wang, Rachel Yehuda, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Focus (American Psychiatric Publishing)|July 5, 2023
Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and SertralineAllison A Feduccia, Lisa Jerome, Berra Yazar-Klosinski, et al.
Frontiers in Pharmacology|June 7, 2021
Relational Processes in Ayahuasca Groups of Palestinians and IsraelisLeor Roseman, Yiftach Ron, Antwan Saca, et al.
Journal of Psychopharmacology (Oxford, England)|June 21, 2022
MDMA-assisted therapy for posttraumatic stress disorder: A pooled analysis of ethnoracial differences in efficacy and safety from two Phase 2 open-label lead-in trials and a Phase 3 randomized, blinded placebo-controlled trialTerence Hw Ching, Monnica T Williams, Julie B Wang, et al.
Journal of Psychiatric Research|March 10, 2022
MDMA-assisted therapy significantly reduces eating disorder symptoms in a randomized placebo-controlled trial of adults with severe PTSDTimothy D Brewerton, Julie B Wang, Adele Lafrance, et al.
Journal of Psychopharmacology (Oxford, England)|June 22, 2017
Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapyMark T Wagner, Michael C Mithoefer, Ann T Mithoefer, et al.
Psychopharmacology|June 6, 2020
Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trialsLisa Jerome, Allison A Feduccia, Julie B Wang, et al.
Psychopharmacology|May 9, 2019
MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trialsMichael C Mithoefer, Allison A Feduccia, Lisa Jerome, et al.
Drug and Alcohol Dependence|March 14, 2022
The effects of MDMA-assisted therapy on alcohol and substance use in a phase 3 trial for treatment of severe PTSDChristopher R Nicholas, Julie B Wang, Allison Coker, et al.
Journal of Psychopharmacology (Oxford, England)|November 23, 2012
Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up studyMichael C Mithoefer, Mark T Wagner, Ann T Mithoefer, et al.
Plos One|January 10, 2024
Effects of MDMA-assisted therapy for PTSD on self-experienceBessel A van der Kolk, Julie B Wang, Rachel Yehuda, et al.
Pageof 4